U.S. Pharma Stock News

In late January 2026, Equity LifeStyle Properties, Inc. reported full-year 2025 results showing higher sales of US$1,282.53 million, revenue of US$1,531.38 million, and net income of US$386.49 million, while also announcing its 22nd consecutive annual dividend increase to US$2.17 per share for 2026 and issuing earnings guidance for the year. The combination of rising normalized Funds From Operations, consistent dividend growth, and management’s 2026 outlook reinforced the REIT’s...

Arch Capital Group Ltd. recently announced that long-serving director and former CFO John Vollaro will not stand for reelection at the May 5, 2026 Annual Meeting, concluding a Board tenure that began in 2009 after senior executive roles from 2002 to 2009. This transition comes as analyst expectations point to higher earnings and revenue for the December 2025 quarter, highlighting how governance continuity and anticipated financial performance are intersecting for the specialty...

In recent weeks, News Corporation announced an expanded US$1.30 billion accelerated stock buyback funded by proceeds from its Foxtel Group divestiture, while highlighting growth in digital, data and subscription-focused operations such as Dow Jones’ B2B services and digital real estate. An interesting angle is the company’s push to defend its intellectual property in the context of AI, which could shape future monetisation of its premium content and data businesses. Next, we’ll examine how...

OSI Systems, Inc. recently reported record second-quarter fiscal 2026 results, with revenue of US$464.06 million and higher net income and earnings per share versus a year earlier, while also completing a sizeable share repurchase program and issuing US$575 million of convertible notes. Growth was led by the Security and Optoelectronics divisions, supported by new contract wins such as screening systems for a major European winter sporting event and participation in large U.S. defense...

Taysha Gene Therapies (NasdaqGS:TSHA) has dosed the first patient in its pivotal REVEAL trial of TSHA-102 for Rett syndrome. The REVEAL study design has received FDA approval, supporting the structure of this key registrational trial. The company expects updated safety and efficacy data from the trial in the first half of 2026. Taysha Gene Therapies enters this next clinical phase with its share price at $4.66 and a 3 year return of 278.9%. The stock has also recorded a 1 year return of...

What stands out about Erasca’s recent trading performance? Erasca (ERAS) has drawn fresh attention after a sharp share price move, with the stock showing a 1 day return of 0.95% and a month return of 195.54%, alongside a past 3 months return of 359.31%. See our latest analysis for Erasca. That sharp move in Erasca’s share price to US$10.61 comes on top of strong short term momentum, with a 30 day share price return of 195.54% and a very large 1 year total shareholder return that is well above...

In January 2026, FTAI Aviation Ltd. announced a multi-year agreement with CFM International to supply OEM parts, thrust performance upgrades, and component repair for CFM56 engines, aiming to extend engine life and support the global narrowbody fleet. This agreement effectively weaves FTAI deeper into the CFM56 maintenance ecosystem, potentially making its engine solutions more integral to airlines’ long-term maintenance planning. We’ll now examine how this expanded CFM56 repair and...

Cellebrite DI Ltd. recently acquired Corellium, a move that adds advanced AI and virtualization technology to its digital intelligence and forensics portfolio and broadens its reach across law enforcement, national security, and private-sector clients. This deal deepens Cellebrite’s capabilities in cybersecurity and defense-related use cases, potentially making its unified Case-to-Closure platform more integral to complex digital investigations. Next, we’ll examine how integrating...

Ross Stores recently reported a strong quarter, with comparable store sales rising and new store openings contributing to growth, while management kept expenses tightly controlled and reduced expected tariff impacts. The retailer’s focus on branded merchandise and refreshed marketing appears to be reinforcing its competitive position, supporting positive analyst sentiment ahead of its upcoming earnings release. Against this backdrop of improved same-store performance, we’ll explore how these...

In late January 2026, Extreme Networks reported fiscal Q2 2026 results showing revenue of US$317.93 million and net income of US$7.88 million, alongside higher full-year guidance for both revenue and earnings per share. Beneath the headline numbers, management pointed to strong demand for its AI-powered Extreme Platform ONE and momentum in subscription-based cloud networking, supported by the launch of its new AI-enabled Extreme Partner First™ program. We’ll now look at how this combination...

Independent Bank Corp. reported past fourth-quarter and full-year 2025 results, with net interest income rising to US$212.49 million for the quarter and US$708.83 million for the year, and quarterly net income increasing to US$75.34 million alongside higher charge-offs. The bank also completed a US$60.86 million share repurchase of 912,528 shares, signaling management’s confidence while full-year earnings per share were slightly lower than the prior year. With recent share gains, we’ll...

In recent weeks, Mattel used the 75th Spielwarenmesse as a high-profile platform for new global product launches, while its Mexican operations adjusted to higher tariffs on Chinese goods that are lifting input costs for local toy makers. These developments highlight how Mattel is both leveraging premium industry exposure and managing shifting trade conditions that could alter competitive and cost structures across its supply chain. We’ll now examine how Mattel’s new product launches at...

Brookdale Senior Living recently issued guidance for 2025, projecting revenue of about US$3.20 billion versus US$3.10 billion in 2024, alongside a wider net loss of approximately US$263 million due largely to non-cash impairment charges. At the same time, the company outlined ambitious 2026 targets for revenue per available room growth and adjusted EBITDA, signaling management’s confidence in extracting more earnings power from its existing senior housing footprint. Next, we’ll examine how...

Fulton Financial Corporation recently reported its fourth-quarter and full-year 2025 results, showing higher net interest income and net income versus the prior year, while also modestly increasing net loan charge-offs and completing a multi-year share repurchase program totaling 3,286,445 shares for US$59.72 million. Alongside these figures, management pointed to meaningful momentum in consumer demand deposit account openings and strong loan origination trends, underscoring how its...

In recent weeks, UFC and Good Greek Moving & Storage announced a multiyear marketing partnership that will place Good Greek branding inside selected U.S. UFC Fight Nights and all episodes of Dana White’s Contender Series, supported by athlete-led campaigns, while analysts highlighted initiatives such as Zuffa Boxing and growing sponsorships across UFC and WWE. At the same time, TKO Group Holdings expanded its revolving credit facility to €1.15 billion and continued to push global UFC event...

Streamex (STEX) has been getting fresh attention after teaming up with tZERO to support secondary trading of GLDY, a gold linked tokenized security, on a regulated alternative trading system. See our latest analysis for Streamex. At a share price of US$3.33, Streamex has had a mixed run, with a 7.07% 1 month share price return and 7.07% year to date share price return, but a 26.65% 3 month share price decline and a 71.54% 3 year total shareholder return decline alongside a very large 1 year...

Helios Technologies recently expanded its OpenView display platform by adding CODESYS functionality, allowing customers to program both uControl controllers and OpenView displays within the same industrial development environment while enabling remote visualization and diagnostics through CODESYS WebVisu. This move reinforces Helios’ open software approach and could make its Electronics segment more attractive to OEMs and system integrators seeking interoperable, future-ready HMI...

Federated Hermes, Inc. recently reported fourth-quarter 2025 results with higher revenue and net income year over year, affirmed a US$0.34 quarterly dividend, completed share repurchases under two authorizations, and announced that senior portfolio manager Mark Weiss, CFA, will lead the Prime Liquidity Group when longtime executive Paige Wilhelm retires on July 1, 2026. This combination of solid operating updates and a planned leadership handover in a US$242.7 billion prime money market...

Why Soleno Therapeutics Is Back on Investors’ Radar Soleno Therapeutics (SLNO) is drawing fresh attention after describing 2025 as a transformational year, highlighting early traction for VYKAT XR, and flagging upcoming full financial results alongside a busy investor conference schedule. See our latest analysis for Soleno Therapeutics. The latest 9.75% 1 day share price gain to US$42.32 comes after management framed 2025 as transformational and highlighted early VYKAT XR traction. However,...

Sysco Corporation recently reported its second-quarter and six-month results to December 27, 2025, with sales rising to US$20,762 million for the quarter and US$41,910 million for the half-year, while net income and earnings per share from continuing operations were slightly lower than a year earlier. A new four-year collective bargaining agreement for more than 50 Sysco drivers in Spokane, Washington, featuring a very large wage increase and improved benefits, highlights how the company is...

Hagerty (HGTY) has been drawing attention after recent share price moves, with the stock showing mixed short term performance and a stronger picture over the past year. This has prompted investors to reassess the specialty insurer. See our latest analysis for Hagerty. At a share price of US$12.68, Hagerty’s recent 90 day share price return of 13.82% contrasts with a 1 month share price decline of 3.57%, while the 1 year total shareholder return of 31.4% points to momentum that has played out...

Autolus Therapeutics plc ( NASDAQ:AUTL ) shareholders won't be pleased to see that the share price has had a very rough...

EOG Resources (EOG) recently posted quarterly results, reporting revenue slightly below the prior year while adjusted EPS came in ahead of expectations, supported by strong free cash flow, shareholder payouts, and ongoing interest in natural gas demand. See our latest analysis for EOG Resources. Those earnings helped steady sentiment after a 1 year total shareholder return decline of about 11%, even as the 90 day share price return of roughly 3% and 5 year total shareholder return of about...

How Gen Digital’s recent performance sets the stage for investors Gen Digital (GEN) has drawn attention after a recent stretch of weaker share performance, with the stock showing negative returns over the past week, month, past 3 months and year. Alongside that price pressure, the company reports annual revenue of US$4.47b and net income of US$570.0m, giving investors a concrete baseline to compare its current valuation against recent fundamental results. See our latest analysis for Gen...